Have you ever tried to seesaw alone? Imagine the scene: a playground with two seesaws. On one sits a doctor. On the other one, a patient. The seesaw itself is your brand’s messaging – one seesaw has just HCP messaging and the other only DTC messaging. The doctor and the patient are both interacting with their seesaws – sitting motionless, perhaps even trying to make the seesaw move. But the magic really happens when you introduce one seesaw that integrates the messaging, placing both HCP and consumer together. The seesaw can finally move, and they’re together, interacting, integrating.
Industry contributors shared with Med Ad News topics that will have a major impact on pharma marketing during 2020.
A look at how the California Consumer Privacy Act put into effect in 2020 will impact the pharmaceutical industry.
23andMe announced that the company was laying off about 100 employees as sales were down, reflecting a shrinking market for DNA test kits to consumers.
By David Reim, Chief Privacy Officer at DMD The California Consumer Privacy Act (CCPA) is now the law of the land. California is home to 12% of the country’s consumers, […]
Merkle’s webinar will show how to harness Artificial Intelligence (AI) to better understand data and enhance future consumer-brand interactions.
Pharma is in digital hyperdrive, and the job market looks nothing like it did in the past. Pharma marketers who ignore changes risk losing their competitive edge.
TBWA\WorldHealth Chief Strategy Officer Paul Pfleiderer, PhD, authored a white paper focused on the growing influence and importance of radio.
Johnson & Johnson said recent tests showed that Johnson’s Baby Powder was free of asbestos, after FDA investigations reported trace amounts of the material in the product earlier in 2019.
Johnson & Johnson said recent tests showed that Johnson’s Baby Powder was free of asbestos, after FDA investigations reported trace amounts of the material in the product earlier in 2019.
